Effective treatment of anemia in pediatric kidney transplant recipients with methoxy polyethylene glycol-epoetin beta

Pediatric Transplantation

Volumn 15, Issue 3, 2011, Pages 329-333

  Wedekin, Mirja ^a   Ehrich, Jochen H H ^a   Pape, Lars ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

anemia; children; methoxy polyethylene glycol epoetin beta; renal transplantation

Indexed keywords

C REACTIVE PROTEIN; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; CYCLOSPORIN A; EVEROLIMUS; FERRITIN; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PARATHYROID HORMONE; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TRANSFERRIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FERRITIN BLOOD LEVEL; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON THERAPY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PARATHYROID HORMONE BLOOD LEVEL; PEDIATRIC SURGERY; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ANEMIA; CHILD; DRUG CARRIERS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; TRANSFERRIN; TREATMENT OUTCOME;

EID: 79955028623     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01476.x     Document Type: Article

References (22)

1. Al-Uzri A, Yorgin PD, Kling PJ,. Anemia in children after transplantation: Etiology and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant 2003: 7: 253-264. (Pubitemid 36988279)
2. Montanaro D,. Anemia after renal transplantation. G Ital Nefrol 2007: 24: 13-22.
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE,. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996: 28: 53-61. (Pubitemid 26231466)
4. Walter T, De Andraca I, Chadud P, Perales CG,. Iron deficiency anemia: Adverse effects on infant psychomotor development. Pediatrics 1989: 84: 7-17. (Pubitemid 19168032)
5. Brandt JR, Avner ED, Hickman RO, Watkins SL,. Safety and efficacy of erythropoietin in children with chronic renal failure. Pediatr Nephrol 1999: 13: 143-147. (Pubitemid 29206242)
6. Van Damme-Lombaerts R, Broyer M, Businger J, Baldauf C, Stocker H,. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis. Pediatr Nephrol 1994: 8: 338-342. (Pubitemid 24162276)
7. Warady BA, Arar MY, Lerner G, Nakanishi AM, Stehman-Breen C,. Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr Nephrol 2006: 21: 1144-1152. (Pubitemid 44083889)
8. André J-L, Deschenes G, Boudailliez B, et al., Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure. Pediatr Nephrol 2007: 22: 708-714. (Pubitemid 46691528)
9. Durkan AM, Keating LE, Vigneux A, Geary DF,. The use of darbepoetin in infants with chronic renal impairment. Pediatr Nephrol 2006: 21: 694-697.
10. Geary DF, Keating LE, Vigneux A, Stephens D, Hebert D, Harvey EA,. Darbepoetin alfa (Aranesp) in children with chronic renal failure. Kidney Int 2005: 68: 1759-1765. (Pubitemid 43169920)
11. Lerner G, Kale AS, Warady BA, et al., Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatr Nephrol 2002: 17: 933-937. (Pubitemid 36097394)
12. Schmitt CP, Nau B, Brummer C, Rosenkranz J, Schaefer F,. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients. Nephrol Dial Transplant 2006: 21: 3520-3524. (Pubitemid 44817103)
13. Curran MP, Mccormack PL,. Methoxy polyethylene glycol-epoetin beta: A review of its use in the management of anaemia associated with chronic kidney disease. Drugs 2008: 68: 1139-1156. (Pubitemid 351693680)
14. KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007: 50: 471-530.
15. Schwartz GJ, Munoz A, Schneider MF, et al., New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009: 20: 629-637.
16. Mitsnefes MM, Subat-Dezulovic M, Khoury PR, Goebel J, Strife CF,. Increasing incidence of post-kidney transplant anemia in children. Am J Transplant 2005: 5: 1713-1718. (Pubitemid 40910454)
17. Kausman JY, Powell HR, Jones CL,. Anemia in pediatric renal transplant recipients. Pediatr Nephrol 2004: 19: 526-530. (Pubitemid 38594291)
18. Yorgin PD, Belson A, Sanchez J, et al., Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 2002: 40: 1306-1318. (Pubitemid 35403145)
19. Smith LB, Fadrowski JJ, Howe CJ, Fivush BA, Neu AM, Furth SL,. Secondary hyperparathyroidism and anemia in children treated by hemodialysis. Am J Kidney Dis 2010: 55: 326-334.
20. Fliser D, Kleophas W, Dellana F, et al., Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: The MIRACEL study. Curr Med Res Opin 2010: 26: 1826.
21. HOFFMANN-LA ROCHE I. Full Prescribing Information (US): Mircera (Methoxy Polyethylene Glycol-Epoetin Beta). Nutley, NJ: Hoffmann-La Roche Inc., 2007.
22. Ibbotson T, Goa KL,. Darbepoetin alfa. Drugs 2001: 61: 2097-2104; discussion 105-6. (Pubitemid 33135186)